Active Research
TOTAL FEEDBACK
The study entitled Translation of a Diagnostic Test for Lupus Flare Prediction from Bench to Clinic (TOTAL FEEDBACK) is investigating the presence of certain blood proteins before and after a lupus flare has occurred.
One of the hallmarks of systemic lupus erythematosus (SLE) is periodic ‘flares,’ a period of increased disease activity, which can lead to a reduced quality of life or even hospitalization.
Progentec recruited patients at several locations across the United States. We are working with both patients and rheumatologists to evaluate and study patient’s bloodwork over the span of six months. The findings of TOTAL FEEDBACK will directly aid in the development of future technologies.
Continuing Progentec’s predictive research, our team has partnered with two Lupus Centers of Excellence in the United States: the Mayo Clinic and the Oklahmoa Medical Research Foundation. Patients at both locations were recruited to participate in this study with the goal of supporting the development and refinement of technologies to support the care of people with lupus.
Active Research
The OASIS study is a decentralized clinical study analyzing the power of digital signals. Using patient generated health data (PGHD) from validated surveys and wearable device data, Progentec is creating digital biomarkers to measure and predict changes in lupus disease activity
People can participate in the study without making any changes to their treatment plan or visiting the doctor's office. Participants download the LupusCorner Research App. Surveys and other activities are completed from within the app. A select number of participants also receive the Withings Steel HR smartwatch.
Visit the OASIS Study Landing Page
NCT ID: NCT04449653 View on ClinicalTrials.gov
Looking for our previous studies?
Questions? Interested in participating in research?
Reach out the Progentec Clinical Research team: clinical.research@progentec.com